Synthetic Peptide
Human nNOS (residues 1411-1425) Synthetic Peptide, PEP-190, from Invitrogen.
NOS activity requires homodimerization as well as three cosubstrates (L-arginine, NADPH and O2) and five cofactors or prosthetic groups (FAD, FMN, calmodulin, tetrahydrobiopterin and heme). Several distinct NOS isoforms have been described and been shown to represent the products of three distinct genes. These include two constitutive Ca2+/CaM-dependent forms of NOS, including NOS1 (also designated ncNOS) whose activity was first identified in neurons, and NOS3 (also designated ecNOS), first identified in endothelial cells.
| Marque | Invitrogen |
|---|---|
| Réf. B-LABO | BL-RE-176256 |
| Réf. fabricant | 11584840 |
| Gene ID (Entrez) | 4842 |
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d’adhésion | P29475 |
| Nom usuel | Human nNOS (aa 1411-1425) |
| Concentration | 0.5 mg/mL |
| Contenu et stockage | -20°C. Avoid freeze-thaw cycles. |
| Format | Lyophilized |
| Formule | peptide with no preservative |
| À utiliser avec (application) | Control |
| Symbole de gène(s) | NOS1 |
| Lyophilisé | Lyophilized |
| Conservateur | No preservative |
| Type de produit | Peptide |
| Quantité | 50 μg |
| État réglementaire | RUO - research use only |
| Séquence | C N(1411) R L R S E S I A F I E E S K(1425) |
